Journal Watch · Journal of Controlled Release · 2026
Rapidly gelling platelet-rich plasma-loaded carboxymethyl hydroxybutyl chitosan hydrogel for colonic repair and adhesion reduction.
Together, the strong tissue adhesion of CHC and the immunomodulatory function of PRP provide a promising sutureless strategy for repairing high-risk intra-abdominal visceral injuries.
TL;DR
Together, the strong tissue adhesion of CHC and the immunomodulatory function of PRP provide a promising sutureless strategy for repairing high-risk intra-abdominal visceral injuries.
Key findings
- In rat and New Zealand rabbit full-thickness colonic defect models, the composite hydrogel significantly accelerated mucosal repair and reduced postoperative adhesions.
- Mechanistically, PRP activated the PI3K/Akt pathway, promoting macrophage polarization toward the M2 phenotype and shifting cellular metabolism toward oxidative phosphorylation, thereby establishing a local anti-inflammatory microenvironment.
- Together, the strong tissue adhesion of CHC and the immunomodulatory function of PRP provide a promising sutureless strategy for repairing high-risk intra-abdominal visceral injuries.
What they did
CHC remains fluid at 4 °C, allowing homogeneous mixing with PRP at a 4:1 ratio while preserving growth factor bioactivity. Upon exposure to 37 °C, the mixture rapidly gels within 10 s, achieving a shear adhesive strength of 75 kPa, sufficient to withstand intestinal pressure fluctuations and enable sustained growth factor release.
Full abstract (original)
Background: Colonic wound repair remains limited by poor material adhesion and postoperative intra-abdominal adhesions. Platelet-rich plasma (PRP) was incorporated into an externally supplied thermosensitive carboxymethyl hydroxybutyl chitosan (CHC) matrix to prepare a composite hydrogel for colonic wound repair.
What they did: CHC remains fluid at 4 °C, allowing homogeneous mixing with PRP at a 4:1 ratio while preserving growth factor bioactivity. Upon exposure to 37 °C, the mixture rapidly gels within 10 s, achieving a shear adhesive strength of 75 kPa, sufficient to withstand intestinal pressure fluctuations and enable sustained growth factor release.
Results & conclusions: In rat and New Zealand rabbit full-thickness colonic defect models, the composite hydrogel significantly accelerated mucosal repair and reduced postoperative adhesions. Mechanistically, PRP activated the PI3K/Akt pathway, promoting macrophage polarization toward the M2 phenotype and shifting cellular metabolism toward oxidative phosphorylation, thereby establishing a local anti-inflammatory microenvironment. Together, the strong tissue adhesion of CHC and the immunomodulatory function of PRP provide a promising sutureless strategy for repairing high-risk intra-abdominal visceral injuries.
Abstract © the authors / Journal of Controlled Release (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.jconrel.2026.115027 · PubMed 42142742.
Why it matters for pharma & biotech
- Relevant to Pharmacology & Drug Discovery teams tracking Journal of Controlled Release for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Journal of Controlled Release study find?
Together, the strong tissue adhesion of CHC and the immunomodulatory function of PRP provide a promising sutureless strategy for repairing high-risk intra-abdominal visceral injuries.
What type of study is this?
It is a research study, published in Journal of Controlled Release in 2026. CHC remains fluid at 4 °C, allowing homogeneous mixing with PRP at a 4:1 ratio while preserving growth factor bioactivity.
Where can I read the original paper?
The original is at the publisher via DOI 10.1016/j.jconrel.2026.115027. PubMed ID: 42142742. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/rapidly-gelling-platelet-rich-plasma-loaded-carboxymethyl-hydroxybutyl-c-115027/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides